Patents - Global Data - Dimensions
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS
Applicants:
- Genmab (Denmark) [NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]
- BioNTech (Germany) [NORA names: Germany; Europe, EU; OECD]
- Individual [NORA names: Miscellaneous; Miscellaneous]
- Msd International Business GmbH
- Genmab AS [NORA names: Genmab; Private Research]
(... more)
Abstract
The present disclosure relates to combination therapy using a binding agent that binds to human PD-L1 and to human CD 13 7 in combination with pembrolizumab to reduce or prevent progression of a tumor or treating cancer.
Patent Family Records (5)
Multispecific binding agent for PD-L1 and CD137 in combination with anti-PD-1 antibody for treating cancer
비온테크 에스이, 엠에스디 인터내셔널 비즈니스 게엠베하, 젠맵 에이/에스 뉘름베르거, 크리스티나, 무이크, 알렉산더, 사힌, 우구르, (...more)
2024, KR-20240082387-A
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS
BioNTech (Germany), BioNTech SE, GENMAB AS, Genmab (Denmark), JURE KUNKEL MARIAN, MSD INT BUSINESS GMBH, MUIK ALEXANDER, N?RMBERGER KRISTINA, PENCHEVA NORA, SAHIN UGUR JURE-KUNKEL MARIAN, SAHIN UGUR, MUIK ALEXANDER, (...more)
2024, IL-311901-A
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS
BioNTech (Germany), Biontech SE, Genmab (Denmark), Genmab AS, Msd Int Business GmbH MUIK ALEXANDER, N?RMBERGER KRISTINA, NÜRMBERGER KRISTINA, (...more)
2024, AU-2022360108-A1
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS
BioNTech (Germany), BioNTech SE, GENMAB AS, Genmab (Denmark), MSD INT BUSINESS GMBH MUIK ALEXANDER, SCHÖDEL KRISTINA, PENCHEVA NORA, (...more)
2023, WO-2023057535-A1
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS
Individual MUIK ALEXANDER, NURMBERGER KRISTINA, PENCHEVA NORA, (...more)
2023, CA-3233512-A1
